跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,238 条关于
“Pharos iBio”
全部
5,238
临床试验
930
药物
1,241
机构
1,185
资讯
1,882
去年
Pharos iBio's PHI-101 Demonstrates Promising Complete Response in AML Phase 1 Trial
11个月前
iBio to Present Preclinical Data on First-in-Class Activin E Antibody IBIO-610 for Obesity Treatment
6个月前
iBio's IBIO-610 Shows Fat-Selective Weight Loss in Non-Human Primate Study
10个月前
iBio's IBIO-610 Activin E Antibody Shows 100-Day Human Half-Life Potential for Twice-Yearly Obesity Treatment
去年
iBio Advances AI-Driven Obesity Pipeline with Myostatin and Activin E Antibody Therapies
6个月前
iBio Advances Bispecific Antibody for Pulmonary Hypertension in Heart Failure, Targets Q3 2026 Development Candidate
去年
iBio Licenses First-in-Class Antibody Targeting Activin E for Obesity and Cardiometabolic Diseases
11个月前
Pfizer's BRAFTOVI Plus MEKTOVI Achieves Nearly Four-Year Survival in BRAF-Mutant Lung Cancer
2年前
European Commission Approves Encorafenib and Binimetinib Combination for BRAF V600E-Mutant NSCLC
11个月前
Pfizer Presents Breakthrough Cancer Data at ESMO 2025, Showcasing Unprecedented Survival Results
第 1 页,共 189 页
上一页
下一页